ArticlePharmacoEconomics2022

The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.

Ali Tafazzoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.